Doctronic navigation menu Log In
Doctronic navigation menu

Contents
  • Preparing for Surgery with VWD
  • Managing VWF Levels During Surgery
  • Addressing Potential Complications

What to Know About Surgery with Von Willebrand Disease

What to Know About Surgery with Von Willebrand Disease

Surgical Insights

Surgery in patients with von Willebrand Disease (VWD) requires special considerations. This article outlines the key strategies for managing VWD during major surgical procedures.
Contents
  • Preparing for Surgery with VWD
  • Managing VWF Levels During Surgery
  • Addressing Potential Complications

Preparing for Surgery with VWD

For individuals with VWD, preparation for surgery involves raising VWF levels to ensure proper clotting. This is done by administering VWF concentrates intravenously before the procedure. The goal is to achieve a VWF activity level of about 100 IU/dL, checked in the recovery room to avoid delays.

Managing VWF Levels During Surgery

VWF levels are maintained above 50 IU/dL throughout the surgery using repeated infusions. The frequency of infusions, typically every 8 to 12 hours, is determined based on the patient's response and clinical picture. Continuous monitoring ensures any rapid clearance or recovery issues are promptly addressed.
Von Willebrand Disease (VWD) is a genetic blood disorder that affects the body's ability to clot properly, posing challenges during surgical procedures.

Addressing Potential Complications

During surgery, complications like thrombosis may arise if factor VIII levels become excessively elevated. Careful monitoring helps prevent such risks by adjusting dosages. In some cases, continuous infusion of VWF may be necessary to manage inhibitors effectively.

FAQs

How are VWF levels managed during surgery?

Levels are maintained above 50 IU/dL with repeated infusions.

What is the target VWF activity level before surgery?

The target level is about 100 IU/dL.

Why is continuous monitoring important during surgery?

It helps manage rapid clearance and prevent complications.

Wrapping Up

Effective management of VWF levels is essential for safe surgical outcomes in VWD patients.
Planning surgery with VWD? Talk to Doctronic about your options.
Additional References
  1. Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008; 14:171.
  2. Peyvandi F, Mamaev A, Wang JD, et al. Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery. J Thromb Haemost 2019; 17:52.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.